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antibiotics increased from 53% to 56% at initial visits for
AOM. The increase was statistically signiﬁcant compared
to controls. The increase was greatest among emergency
room physicians, while remaining unchanged among
family medicine physicians. Characteristics of prescribers
who were most responsive to the intervention were
further described using multivariate analyses. CONCLU-
SIONS: The intervention achieved a statistically signiﬁ-
cant increase of prescription rate of ﬁrst line antibiotics
in the treatment of initial visits for AOM in children after
a single mailing, but the magnitude of change was not
large.
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OBJECTIVES: To determine the feasibility, validity 
and reliability of KINDL in an Asian school-based
sample. Introduction: KINDL-Kid and KINDL-Kiddo
have been culturally adapted and tested in a sample of
diabetic and healthy children in Singapore with promis-
ing results. Testing of KINDL was extended to a school-
based sample more representative of the general children
population. METHODS: Invitations for participations
were sent to all schools in Singapore after permission was
obtained from the Ministry of Education. Students aged
8–16 years old from participating schools were randomly
selected. After the purpose of the study was explained,
the questionnaires were administered and the participants
were asked to complete the questionnaire without seeking
their friends’ opinions. The students were asked to report
if they had any of the chronic conditions such as asthma
and diabetes. RESULTS: A total of 328 participants 
completed KINDL-Kid (mean score: 68.3 ± 12.57%)
while 1026 completed KINDL-Kiddo (mean score: 59.3
± 11.64%). 25 KINDL-Kid and 56 KINDL-Kiddo par-
ticipants were asthmatics. Majority of participants in
both groups were Chinese (KINDL-Kid: 74.1%, KINDL-
Kiddo: 75.2%) and females (KINDL-Kid: 67.0%; and
KINDL-Kiddo: 71.5%). The reliability coefﬁcients (Cron-
bach’s alpha) ranged from 0.4040 to 0.7091 for KINDL-
Kid and 0.3971 to 0.8448 for KINDL-Kiddo. The ceiling
effect was signiﬁcant (>5.0%) in four KINDL-Kid sub-
scales but only one KINDL-Kiddo subscale, while signif-
icant ﬂooring effect was observed in one subscale of both
instruments. KINDL-Kiddo demonstrated discriminant
validity (Healthy vs. Self-reported asthmatics: 56.6 ±
11.92% vs. 51.3 ± 13.21%, p < 0.005) but not KINDL-
Kid (65.5 ± 12.76% vs.66.3 ± 12.71%; p = 0.768). 
CONCLUSION: The scale reliability obtained suggested
a need to re-evaluate the factor structures of KINDL. A
factor analysis may be warranted before KINDL is used
in Singapore on a large scale.
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OBJECTIVE: The use of botulinum toxin type A (BTX)
in the management of spasticity in childhood CP is
increasing. Improvement of physical functioning has been
demonstrated in short-term clinical trials, but not in
prospective longitudinal studies. We examined both 
child physical functioning and parent-caregiver related
psychosocial outcomes related to this treatment in a lon-
gitudinal setting. METHODS: A prospective cohort study
with annual follow-ups for 2 years was conducted in 172
children with spastic type of cerebral palsy receiving Bot-
ulinum Toxin-A (BTX) injections for spasticity manage-
ment in a large academic medical center setting. A mixed
modeling procedure with baseline status confounder
adjustment was used to identify changes in both physical
functioning outcomes for the child (using the WEEFIM
measure) as well as quality of life of the parent caregiver
(using the Stein and Reissman Family Impact Scale) with
increasing utilization of BTX injections. RESULTS: Each
child received an average of 3 BTX injections each year
(range: 1–13). Baseline values of outcome variables indi-
cated poor physical functioning in children and signiﬁ-
cant quality of life burden on the parent caregiver. The
study found that each additional BTX injection adminis-
tration was associated with a 2.3% improvement in 
the WEEFIM, compared to average baseline score (p =
0.004). Similarly, the study found an improvement of 1%
in the parents overall perception of the severity of the
child’s condition Family Impact Scale with each addi-
tional BTX injection administration (p = 0.008). This
reduced perception of severity was in turn, associated
with a decreased family impact score. CONCLUSIONS:
These ﬁndings suggest that treatment with BTX injections
are associated with signiﬁcant improvements in both
physical functioning of the child with cerebral palsy as
well as the quality of life of the child’s parent caregiver.
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